Evidence map›Paper›PMID 26561487›Full record

ArticleInternational journal of peptide research and therapeutics2015

Multiple Bacteriophage Selection Strategies for Improved Affinity of a Peptide Targeting ERBB2.

Benjamin M Larimer, Jeanne M Quinn, Kevin Kramer, Andrey Komissarov, Susan L Deutscher

Abstract read
In one paragraph

Article in International journal of peptide research and therapeutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Benjamin M LarimerResearch Service, Harry S. Truman Veterans Memorial Hospital, Columbia, MO, 65211, USA ; Department of Biochemistry, University of Missouri, 117 Schweitzer Hall, Columbia, MO, 65211, USA.
Jeanne M QuinnDepartment of Biochemistry, University of Missouri, 117 Schweitzer Hall, Columbia, MO, 65211, USA.
Kevin KramerDepartment of Biochemistry, University of Missouri, 117 Schweitzer Hall, Columbia, MO, 65211, USA.
Andrey KomissarovDepartment of Biochemistry, University of Texas Health Care Center Tyler, Tyler, TX, 75708, USA.
Susan L DeutscherResearch Service, Harry S. Truman Veterans Memorial Hospital, Columbia, MO, 65211, USA ; Department of Biochemistry, University of Missouri, 117 Schweitzer Hall, Columbia, MO, 65211, USA.
Harry S. Truman Memorial Veterans' Hospital · USUniversity of Missouri · USThe University of Texas Health Science Center at Tyler · US

Funding

Graduate Training in Radiopharmaceutical ChemistryT32EB004822 · NIBIB · UNIVERSITY OF MISSOURI-COLUMBIA · PI JURISSON, SILVIA S. · 2007 to 2011
$744k
Improved Peptide-based Tumor Targeting Agents Using Phage DisplayR21CA137239 · NCI · UNIVERSITY OF MISSOURI-COLUMBIA · PI DEUTSCHER, SUSAN L · 2009 to 2010
$357k
Phage Display for Improved Peptide-Based Tumor Targeting and Imaging AgentsI01BX000964 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI DEUTSCHER, SUSAN L, SMITH, CHARLES J · 2011 to 2025
–
BLRD VA I01 BX000964NCI NIH HHS R21 CA137239NIBIB NIH HHS T32 EB004822
6 · The paper itself

Abstract

Due to the heterogeneity of ERBB2-expression between tumors and over the course of treatment, a non-invasive molecular imaging agent is needed to accurately detect overall ERBB2 status. Peptides are a highly advantageous platform for molecular imaging, since they have excellent tumor penetration and rapid pharmacokinetics. One limitation of peptides however, is their traditionally low target affinity, and consequently, tumor uptake. The peptide KCCYSL was previously selected from a bacteriophage (phage) display library to bind ERBB2 and did so with moderate affinity of 295 nM. In order to enhance tumor uptake and clinical utility of the peptide, a novel phage microlibrary was created by flanking the parent sequence with random amino acids, followed by reselection using parallel strategies for high affinity and specific ERBB2 binding in an attempt to affinity maturate the peptide. One limitation of traditional phage display selections is difficulty in releasing the highest affinity phages from the target by incubation of acidic buffer. In an attempt to recover high affinity second-generation peptides from the ERBB2 microlibrary, two elution strategies, sonication and target elution, were undertaken. Sonication resulted in an approximately 50-fold enhancement in recovered phage per round of selection in comparison to target elution. Despite the differences in elution efficiency, the affinities of phage-displayed peptides selected from either strategy were relatively similar. Although both selections yielded peptides with significantly improved affinity in comparison to KCCYSL, the improvements were modest, most likely because the parental peptide binding cannot be improved by additional amino acids.

Indexed as

Affinity MaturationERBB2PeptidesPhage Display

Identifiers

PMID26561487
PMCPMC4637174
OpenAlexW605225379

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.